MEDP logo

MEDP

Medpace Holdings Inc.

$569.74
-$18.43(-3.13%)
63
Overall
60
Value
54
Tech
76
Quality
Market Cap
$15.47B
Volume
183.41K
52W Range
$250.05 - $628.92
Target Price
$561.73

Company Overview

Mkt Cap$15.47BPrice$569.74
Volume183.41KChange-3.13%
P/E Ratio38.3Open$591.36
Revenue$2.1BPrev Close$588.17
Net Income$404.4M52W Range$250.05 - $628.92
Div YieldN/ATarget$561.73
Overall63Value60
Quality76Technical54

No chart data available

About Medpace Holdings Inc.

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Sector: Healthcare
Industry: Diagnostics & Research

Latest News

Analysts Have Conflicting Sentiments on These Healthcare Companies: Sera Prognostics (SERA), Medpace Holdings (MEDP) and LENZ Therapeutics (LENZ)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sera Prognostics (SERA – Research Report), Medpace...

Brian Andersona month ago
ABCD
1SymbolPriceChangeVol
2MEDP$569.74-3.1%183.41K
3
4
5
6

Get Medpace Holdings Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.